Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Total Liabilities (2016 - 2025)

Chemours (CC) has 12 years of Total Liabilities data on record, last reported at $7.1 billion in Q4 2025.

  • For Q4 2025, Total Liabilities rose 2.8% year-over-year to $7.1 billion; the TTM value through Dec 2025 reached $7.1 billion, up 2.8%, while the annual FY2025 figure was $7.1 billion, 2.8% up from the prior year.
  • Total Liabilities reached $7.1 billion in Q4 2025 per CC's latest filing, down from $7.3 billion in the prior quarter.
  • Across five years, Total Liabilities topped out at $7.5 billion in Q4 2023 and bottomed at $6.3 billion in Q1 2021.
  • Average Total Liabilities over 5 years is $6.8 billion, with a median of $6.7 billion recorded in 2021.
  • Peak YoY movement for Total Liabilities: rose 15.08% in 2023, then fell 7.73% in 2024.
  • A 5-year view of Total Liabilities shows it stood at $6.5 billion in 2021, then rose by 1.0% to $6.5 billion in 2022, then grew by 15.08% to $7.5 billion in 2023, then decreased by 7.73% to $6.9 billion in 2024, then rose by 2.8% to $7.1 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $7.1 billion in Q4 2025, $7.3 billion in Q3 2025, and $7.2 billion in Q2 2025.